{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-024081","form_type":"8-K","ticker":"CPHI","cik":"0001106644","company_name":"CHINA PHARMA HOLDINGS, INC.","filed_at":"2023-03-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:43.880889+00:00","generated_at":"2026-06-17T09:57:39.888494+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"China Pharma regains NYSE American price compliance but remains under equity plan with delisting risk","bullets":["Resolved low selling price deficiency via 1-for-10 reverse stock split on March 6, 2023.","Still non-compliant with stockholders' equity standards (Sections 1003(a)(ii) and (iii)).","Must achieve full compliance by December 15, 2023 or face delisting proceedings.","\".BC\" indicator remains on ticker CPHI.","If average share price falls below $0.20 over 30 days, immediate review."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-024081","json":"https://secwatch.observer/filing/0001213900-23-024081.json","markdown":"https://secwatch.observer/filing/0001213900-23-024081.md","text":"https://secwatch.observer/filing/0001213900-23-024081.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1106644/000121390023024081/0001213900-23-024081-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1106644/000121390023024081/ea175993-8k_chinapharma.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T09:57:39.888494+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}